Please login to the form below

Not currently logged in
Email:
Password:

Tecfidra

This page shows the latest Tecfidra news and features for those working in and with pharma, biotech and healthcare.

Tecfidera successor’s side-effect profile boosts Biogen

Tecfidera successor’s side-effect profile boosts Biogen

8%, 15.4% and 14.6% for Vumerity 40.6%, 22.3% and 20.7% for Tecfidra).

Latest news

More from news
Approximately 3 fully matching, plus 2 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Anthill Agency

Digital communications agency empowering clients through their digital transformation journey. Whether through training, delivering solutions or devising digital strategies, we...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...